Skip To Content
Current Location:
Home
Departments
Urology
Choung Soo Kim
Share
Print

Medical Staff Introduction

Choung Soo Kim

Choung Soo Kim Professor

Director of Prostate Cancer Center Urology, Prostate Cancer Center, Robot Surgery Center

Specialized Field of Medicine

Prostate cancer, Benign prostatic hyperplasia

Appointment View All Departments

Operating Hours

Paper

  •  Hybrid ileal pouch with concomitant anti-refluxing and refluxing ureteroileal anastomosis.  BMC Urol. 2021 Jun 11;21(1):92. 
  •  Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.  N Engl J Med. 2021 Apr 8;384(14):1289-1300. 
  •  Impact of positive surgical margin on biochemical recurrence in localized prostate cancer.  Prostate Int. 2021 Sep;9(3):151-156. 
  •  Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial.  Clin Cancer Res. 2021 Sep 15;27(18):5004-5011. 
  •  Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy.  Technol Cancer Res Treat. Jan-Dec 2021;20:15330338211024660. 
  •  The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer.  Medicine (Baltimore). 2021 Aug 6;100(31):e26833. 
  •  Prostate cancer trajectory-map: clinical decision support system for prognosis management of radical prostatectomy.  Prostate Int. 2021 Mar;9(1):25-30. 
  •  Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy.  Ann Surg Oncol. 2021 Oct 9. 
  •  Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer.  J Cancer Res Clin Oncol. 2021 May 4. 
  •  Validation of the European association of urology biochemical recurrence risk groups after radical prostatectomy in an Asian cohort and suggestions for refinement.  Urol Oncol. 2021 May;39(5):298.e1-298.e6. 
  •  Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction: an open-label phase 1 clinical trial.  Cytotherapy. 2021 Oct;23(10):931-938. 
  •  Efficacy and tolerability of metallic stent in patients with malignant prostatic obstruction secondary to prostatic cancer.  Low Urin Tract Symptoms. 2021 Jul;13(3):329-334. 
  •  Apalutamide for patients with metastatic castrationsensitive prostate cancer in East Asia: a subgroup analysis of the TITAN trial.  Asian J Androl. 2021 Jul 13. 
  •  Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate.  Sci Rep. 2021 Aug 25;11(1):17194. 
  •  Impact of preoperative chemotherapy on pathologic nodal status in muscle-invasive bladder cancer: optimal lymphadenectomy in the preoperative chemotherapy era.  J Cancer Res Clin Oncol . 2021 Sep 23. 
  •  Does intraoperative frozen section really predict significant positive surgical margins after robot-assisted laparoscopic prostatectomy? A retrospective study.  Asian J Androl. Jan-Feb 2021;23(1):74-79. 
  •  Differential contribution of the factors determining long-term renal function after partial nephrectomy over time..  Urol Oncol. 2021 Mar;39(3):196.e15-196.e20. 
  •  Noninvasive Precision Screening of Prostate Cancer by Urinary Multimarker Sensor and Artificial Intelligence Analysis.  ACS Nano. 2021 Mar 23;15(3):4054-4065. 
  •  Value of clinical parameters and MRI with PI-RADS V2 in predicting seminal vesicle invasion of prostate cancer.  Scand J Urol. 2021 Feb;55(1):17-21. 
  •  External Validation of the Long Short-Term Memory Artificial Neural Network-Based SCaP Survival Calculator for Prediction of Prostate Cancer Survival.  Cancer Res Treat. 2021 Apr;53(2):558-566. 
  •  Width of spared neurovascular bundle after robot-assisted laparoscopic prostatectomy in patients with prostate cancer: is it a reliable factor for predicting postoperative sexual outcome?.  Prostate Int. 2021 Sep;9(3):119-124. 
  •  Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.  N Engl J Med. 2020 Jun 4;382(23):2187-2196. 
  •  Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.  N Engl J Med. 2020 Sep 0;383(11):1040-1049. 
  •  Answer AI for prostate cancer: Clinical outcome prediction model and service.  PLoS One. 2020 Aug 5;15(8):e0236553.. 
  •  Association of Bacillus Calmette-Guerin shortages with bladder cancer recurrence: A single-center retrospective study.  Urol Oncol. 2020 Nov;38(11):851.e11-851.e17. 
  •  Epigenetic regulation of miR-29a/miR-30c/DNMT3A axis controls SOD2 and mitochondrial oxidative stress in human mesenchymal stem cells.  Redox Biol. 2020 Oct;37:101716. 
  •  Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR).  Radiat Oncol. 2020 Oct 8;15(1):234. 
  •  United in Fight against prOstate cancer (UFO) registry: first results from a large, multi-centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia.  BJU Int. 2020 Apr;125(4):541-552. 
  •  Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.  N Engl J Med. 2020 Jun 4;382(23):2197-2206. 
  •  Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells.  Cell Mol Life Sci. 2020 Jan 1. 
  •  Enzalutamide in chemotherapy-naive patients with metastatic castration- resistant prostate cancer: A retrospective Korean multicenter study in a real- world setting.  Investig Clin Urol. 2020 Jan;61(1):19-27. 
  •  Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?.  Clin Genitourin Cancer. 2020 Feb;18(1):50-55. 
  •  Surgical details and renal function change after robot-assisted partial nephrectomy.  Int J Urol. 2020 May;27(5):457-462. 
  •  Luteinizing Hormone Levels Relate to the Unfavorable Pathology of Prostate Cancer.  J Clin Med. 2020 Apr 29;9(5):1281. 
  •  Establishment of NOAEL for intracavernous injections of human bone marrow-derived mesenchymal stem cells in rats.  Investig Clin Urol. 2020 Jan;61(1):88-98. 
  •  Cause of mortality after radical prostatectomy and the impact of comorbidity in men with prostate cancer: A Multi-Institutional Study in Korea.  Cancer Res Treat. 2020 Jul 3. 
  •  Does intraoperative frozen section really predict significant positive surgical margins after robot- assisted laparoscopic prostatectomy? A retrospective study.  Asian J Androl. 2020 May 1. 
  •  Active learning for accuracy enhancement of semantic segmentation with CNN- corrected label curations: Evaluation on kidney segmentation in abdominal CT.  Sci Rep. 2020 Jan 15;10(1):366. 
  •  Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer..  J Cancer Res Clin Oncol. 2020;146(2):537-543. 
  •  Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.  N Engl J Med. 2019 Mar 28;380(13):1235-1246. 
  •  Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.  N Engl J Med. 2019 Jul 4;381(1):13-243:. 
  •  Report of the third Asian Prostate Cancer study meeting Prostate Int.  Prostate Int. 2019 Jun;7(2):60-67. 
  •  The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration- resistant prostate cancer by activating the endoplasmic reticulum stress pathway.  J Exp Clin Cancer Res. 2019 Aug 6;38(1):342. 
  •  Application of 3-D Printed Kidney Model in Partial Nephrectomy for Predicting Surgical Outcomes: A Feasibility Study.  Clin Genitourin Cancer. 2019 Oct;17(5):e878-e884. 
  •  Circulating Tumor Cell Counts in Patients With Localized Prostate Cancer Including Those Under Active Surveillance.  In Vivo. 2019 Sep-Oct;33(5):1615-1620. 
  •  Association of Muscle Mass with Survival after Radical Prostatectomy in Patients with Prostate Cancer.  J Urol. 2019 Sep;202(3):525-532. 
  •  Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer N Engl J.  N Engl J Med. 2020 Jun 4;382(23):2197-2206. 
  •  Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far?.  Surg Oncol. 2019 Sep;30:109-116. 
  •  Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette-Guérin immunotherapy.  J Cancer Res Clin Oncol. 2019 Aug;145(8):2131-2140. 
  •  Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer.  Int J Clin Oncol. 2019 Oct;24(10):1238-1246. 
  •  Stratification based on adverse laboratory/pathological features for predicting overall survival in patients undergoing radical prostatectomy: A K-CaP registry-based analysis.  Medicine (Baltimore). 2019 Nov;98(45):e17931. 
  •  Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study.  Investig Clin Urol. 2019 May;60(3):195-201. 
  •  Robot-assisted partial nephrectomy is associated with early recovery of renal function: Comparison of open, laparoscopic, and robot-assisted partial nephrectomy using DTPA renal scintigraphy.  J Surg Oncol. 2019 Jun;119(7):1016-1023. 
  •  Development of Integrated Data and Prediction System Platform for the Localized Prostate Cancer.  Stud Health Technol Inform. 2019 Aug 21;264:1506-1507. 
  •  Report of the forth Asian Prostate Cancer (A-CaP) study meeting.  Jpn J Clin Oncol. 2019 Jun 1;49(6):581-586. 
  •  Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.  Sci Rep. 2019 Jun 5;9(1):8305. 
  •  Clinical outcomes and costs of robotic surgery in prostate cancer: a multiinstitutional study in Korea.  Prostate Int. 2019 Mar;7(1):19-24. 
  •  Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer Clin.  Genitourin Cancer. 2019 Jun;17(3):e420-e428. 
  •  Is Primary Androgen Deprivation Therapy a Suitable Option for Asian Patients With Prostate Cancer Compared With Radical Prostatectomy? J Natl Compr.  Canc Netw. 2019 May 1;17(5):441-449. 
  •  Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data Prostate Cancer Prostatic Dis.  Prostate Cancer Prostatic Dis. 2019. Mar;22(1):150-158. 
  •  Percutaneous Obliteration of Urinary Leakage after Partial Nephrectomy Using N-Butyl-Cyanoacrylate Obliteration of the Urinoma with or without Coil Embolization of the Fistula Tract.  J Vasc Interv Radiol. 2019. Dec;30(12):2002-2008. 
  •  pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis.  PLoS One. 2019 Apr 11;14(4):e0215057. 
  •  Vorinostat enhances gefitinib‑induced cell death through reactive oxygen species‑dependent cleavage of HSP90 and its clients in non‑small cell lung cancer with the EGFR mutation .  Oncol Rep. 2019 Jan;41(1):525-533. 
  •  Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate risk classification .  Int J Urol. 2019. Jan;26(1):62-68. 
  •  A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL.  Invest New Drugs. 2019 Apr. 
  •  Hypoxic preconditioned mesenchymal stromal cell therapy in a rat model of renal ischemia-reperfusion injury: development of optimal protocol to potentiate therapeutic efficacy.  Int J Stem Cells. 2018 Nov 30;11(2):157-167. 
  •  Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma?.  Investig Clin Urol. 2018 Nov. 
  •  Patterns of recurrence after salvage radiotherapy encompassing pelvic lymphatics in men with high-risk prostate cancer.  Anticancer Res. 2018 Nov. 
  •  Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy: A retrospective competing-risk analysis from the K-CaP registry.  Medicine (Baltimore). 2018;97(42):e12766. 
  •  Prognostic factors of oncologic outcomes in metastatic chemotherapy-naïve castration-resistant prostate cancer treated with enzalutamide in actual clinical practice in East Asia.  Urol Oncol. 2018;36(9):401. 
  •  Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate risk classification.  Int J Urol. 2019;26:62-68. 
  •  Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data.  Prostate Cancer Prostatic Dis. 2019;22(1):150-8. 
  •  Prognostic Factors Related to Recurrence-Free Survival for Primary Carcinoma in situ of the Bladder after Bacillus Calmette-Guérin: A Retrospective Study.  Urol Int. 2018;101(3):269-276. 
  •  In vitro, in vivo, and clinical tests of a novel flexible ureteroscope for the diagnosis and treatment of kidney and ureteral diseases.  Investig Clin Urol. 2018;59(5):328-334. 
  •  Association between serum levels of insulin-like growth factor-1, bioavailable testosterone, and pathologic Gleason score.  Cancer Med. 2018;7(8):4170-4180. 
  •  Declining incidence of benign lesions among small renal masses treated with surgery: Effect of diagnostic tests for characterization.  Urol Oncol. 2018;36(8):362 e9-362 e15. 
  •  A deep belief network and Dempster-Shafer-based multiclassifier for the pathology stage of prostate cancer.  J Healthc Eng. 2018:4651582. 
  •  Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial.  Trials. 2018 Apr 2;19(1):212. 
  •  Discrimination of local recurrence after radical prostatectomy: value of diffusion-weighted magnetic resonance imaging.  Prostate Int. 2018;6(1):12-17. 
  •  Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.  BMC Cancer. 2018;18(1):271. 
  •  Factors contributing to treatment outcomes of post-prostatectomy incontinence surgery for the selection of the proper surgical procedure for individual patients: A single-center experience.  Neurourol Urodyn. 2018;;37(6):1978-1987. 
  •  Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching study.  J Cancer Res Clin Oncol. 2018;144(4):751-758. 
  •  Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer.  Investig Clin Urol. 2018;59(1):18-24. 
  •  Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients .  PLoS One. 2018;13(1):e0190479. 
  •  Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer.  Invest New Drugs. 2018;36(2):195-205. 
  •  Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.  Oncotarget. 2017; 8(40):68996-69004. 
  •  Downregulation of androgen receptors by NaAsO2 via inhibition of AKT-NF-kappaB and HSP90 in castration resistant prostate cancer.  The Prostate. 2017; 77(10):1128-1136 . 
  •  Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study .  BioMed research international . 2017; 2017:9215930 . 
  •  Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study.  BioMed research international. 2017; 7:39562 . 
  •  Risk of Intravesical Recurrence After Ureteroscopic Biopsy for Upper Tract Urothelial Carcinoma: Does the Location Matter? .  Journal of endourology. 2017; 31(3):259-265 . 
  •  Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy .  Urologia internationalis . 2017 . 
  •  Changes in Weight and Metabolic Syndrome Are Associated With Prostate Growth Rate Over a 5-Year Period .  Urology . 2017; 103:185-190 . 
  •  Does Ureteral Catheter Insertion Decrease the Risk of Urinary Leakage After Partial Nephrectomy in Patients With Renal Cell Carcinoma? .  Clinical genitourinary cancer . 2017; 15(4):e707-e712 . 
  •  Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma .  Journal of cancer research and clinical oncology . 2017 . 
  •  Neurovascular bundle size measured on 3. 0-T magnetic resonance imaging is associated with the recovery of erectile function after robot-assisted radical prostatectomy .  Urologic oncology . 2017; 35(9):542. e511-542. e517 . 
  •  Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors .  Journal of Korean medical science . 2017; 32(3):495-501 . 
  •  Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies? .  World journal of urology . 2017; 35(4):665-673 . 
  •  Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer .  Investigational new drugs . 2017 . 
  •  Clinical genitourinary cancer .  Impact of Tumor Location on Local Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: Implications for Adjuvant Radiotherapy . 2017; 15(2):e199-e204 . 
  •  Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus .  International urology and nephrology . 2017; 49(7):1157-1163 . 
  •  Is suspicious upstaging on multiparametric magnetic resonance imaging useful in improving the reliability of Prostate Cancer Research International Active Surveillance (PRIAS) criteria? Use of the K-CaP registry .  Urologic oncology . 2017; 35(7):459. e457-459. e413 . 
  •  Re-Stratification of Patients with High-Risk Prostate Cancer According to the NCCN Guidelines Among Patients Who Underwent Radical Prostatectomy: An Analysis Based on the K-CaP Registry .  Cancer research and treatment : official journal of Korean Cancer Association . 2017 . 
  •  Prognostic heterogeneity in T3aN0M0 renal cell carcinoma according to the site of invasion .  Urologic oncology . 2017; 35(7):458. e417-458. e422 . 
  •  High throughput differential identification of TMPRSS2-ERG fusion genes in prostate cancer patient urine .  Biomaterials . 2017; 135:23-29 . 
  •  Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy .  Journal of Korean medical science. 2017; 35(4):151. e151-151. e157 . 
  •  Recovery of renal function after administration of adipose-tissue-derived stromal vascular fraction in rat model of acute kidney injury induced by ischemia/reperfusion injury .  International urology and nephrology . 2017; 368(3):603-613 . 
  •  Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer .  The Prostate . 2017; 77(1):60-71 . 
  •  Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-beta (PDGF-beta), and PDGF-beta receptor expression in papillary renal cell carcinoma .  Human pathology . 2017; 61:78-89 . 
  •  Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry .  Japanese journal of clinical oncology . 2017; 47(10):981-985 . 
  •  Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting .  Prostate international . 2017; 5(3):95-103 . 
  •  Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naive, metastatic castration-resistant prostate cancer .  Advanced healthcare materials . 2017; 96(27):e7223 . 
  •  Self-Normalized Detection of ANXA3 from Untreated Urine of Prostate Cancer Patients without Digital Rectal Examination .  Advanced healthcare materials . 2017; 6(17) . 
  •  Induction of immunoglobulin transcription factor 2 and resistance to MEK inhibitor in melanoma cells .  Oncotarget . 2017; 8(25):41387-41400 . 
  •  Obesity as a Risk Factor for Unfavorable Disease in Men with Low Risk Prostate Cancer and its Relationship with Anatomical Location of Tumor .  The Journal of urology . 2017; 198(1):71-78 . 
  •  Comparison of Hand-Assisted Laparoscopic vs Robot-Assisted Laparoscopic vs Open Partial Nephrectomy in Patients with T1 Renal Masses .  Journal of endourology . 2017; 31(4):374-379 . 
  •  Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m2) and the Currently Approved Dose (25 mg/m2) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA .  Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2017; 35(28):3198-3206 . 
  •  Adaptive functional change of the contralateral kidney after partial nephrectomy .  American journal of physiology Renal physiology . 2017; 313(2):F192-f198 . 
  •  Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma .  Clinical genitourinary cancer . 2017 . 
  •  Predictors of female genital organ involvement in radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective analysis of 112 female patients .  International journal of surgery (London, England) . 2017; 47:101-106 . 
  •  Enzalutamide in Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study .  European urology . 2017; 71(2):151-154 . 
  •  Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma .  Journal of cancer research and clinical oncology . 2016; 142(11):2331-2338 . 
  •  Bone marrow-derived mesenchymal stromal cell therapy in a rat model of cavernous nerve injury: Preclinical study for approval .  Cytotherapy . 2016; 18(7):870-880 . 
  •  Comparison of renal functional outcomes in exactly matched pairs between robot-assisted partial nephrectomy using warm ischemia and open partial nephrectomy using cold ischemia using diethylene triamine penta-acetic acid renal scintigraphy .  International urology and nephrology . 2016; 48(5):687-693 . 
  •  New drugs in prostate cancer .  Prostate international . 2016; 4(2):37-42 . 
  •  Is lymphovascular invasion a powerful predictor for biochemical recurrence in pT3 N0 prostate cancer? Results from the K-CaP database .  Scientific reports . 2016; 6:25419 . 
  •  Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-kappaB .  Oncotarget . 2016; 7(26):39796-39808 . 
  •  Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy .  Journal of cancer research and clinical oncology . 2016; 142(7):1651-1657 . 
  •  Comparison of Renal Function between Robot-Assisted and Open Partial Nephrectomy as Determined by Tc 99m-DTPA Renal Scintigraphy .  Journal of Korean medical science . 2016; 31(5):743-749 . 
  •  Simple renal cyst and renal dysfunction: A pilot study using dimercaptosuccinic acid renal Scan .  Nephrology (Carlton, Vic) . 2016; 21(8):687-692 . 
  •  Acute Kidney Injury After Radical Cystectomy for Bladder Cancer is Associated with Chronic Kidney Disease and Mortality .  Annals of surgical oncology. 2016; 23(2):686-693 . 
  •  Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy .  Japanese journal of clinical oncology . 2016; 46(8):762-767 . 
  •  Characteristics of Anteriorly Located Prostate Cancer and the Usefulness of Multiparametric Magnetic Resonance Imaging for Diagnosis .  The Journal of urology . 2016; 196(2):367-373 . 
  •  Three-Dimensional Printing: Basic Principles and Applications in Medicine and Radiology .  Korean journal of radiology . 2016; 17(2):182-197 . 
  •  The PREVAIL trial of enzalutamide in men with chemotherapy-naive, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients .  Investigative and clinical urology . 2016; 57(3):174-183 . 
  •  Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy .  Urologic oncology . 2016; 34(1):3 e9-14 . 
  •  Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of Results .  The Journal of urology . 2016; 195(3):568-573 . 
  •  The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer .  Journal of Korean medical science . 2016; 70(4):675-683 . 
  •  First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry..  Urologic oncology. 2016; 34(5):234.e221-239. 
  •  Asia prostate cancer study (A-CaP Study) launch symposium.  Prostate international. 2016; 4(3):88-96. 

Book

  • 암에 대한 모든 것